Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial
Resource Type
Article
Authors
Delany-Moretlwe, Sinead ; Lombard, Carl ; Baron, Deborah ; Bekker, Linda-Gail ; Nkala, Busi ; Ahmed, Khatija ; Sebe, Modulakgotla ; Brumskine, William ; Nchabeleng, Maposhane ; Palanee-Philips, Thesla ; Ntshangase, Julius ; Sibiya, Sidney ; Smith, Emilee ; Panchia, Ravindre ; Myer, Landon ; Schwartz, Jill L ; Marzinke, Mark ; Morris, Lynn ; Brown, Elizabeth R ; Doncel, Gustavo F ; Gray, Glenda ; Rees, Helen
Source
In The Lancet Infectious Diseases November 2018 18(11):1241-1250
Subject
Primary Research Articles
Language
ISSN
1473-3099